Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 13, Number 12—December 2007
Dispatch

Human and Animal Infections with Mycobacterium microti, Scotland

Francis Xavier Emmanuel*, Amie-Louise Seagar*Comments to Author , Christine Doig*, Alan Rayner*, Pauline Claxton*, and Ian Laurenson*
Author affiliations: *Scottish Mycobacteria Reference Laboratory, Edinburgh, Scotland, United Kingdom;

Main Article

Table 2

Laboratory features of Mycobacterium microti isolates from Scotland*†

Source Specimen Direct AFB Growth on primary isolation
 Drug susceptibility Genotype
Solid culture
 Liquid culture
IUT PYR MB/MGIT
Human 1 Sputum Positive – + – Failed to grow in liquid cultures Llama type SIT641
(spacers 4–7, 23,24, 37, and 38)
Human 2 Sputum Positive
(many) – + – Failed to grow in liquid cultures Llama type SIT641
Human 3 Sputum Positive
(many) – – + Susceptible to R, I, E; resistant to P Llama type SIT641
Human 4 Sputum Positive
(few) + + – Failed to grow in liquid culture Llama type
(spacers 4–7 and 23,24 only)
Cat 1 Tissue/lymph node Negative – + – Failed to grow in liquid cultures Llama type SIT641
Badger Tissue/lung Strongly positive + + ± Inadequate growth Vole type SIT 539
(spacers 37 and 38)
Cat 2 Tissue/lymph node Negative – + – Susceptible to R,I,E,P
(grew on liquid subculture) Vole type SIT539
Llama Tissue/lung Positive + + – Failed to grow in liquid culture Llama type SIT641
Ferret Tissue Positive ± ± ± Susceptible to R,I,E,P Not tested

*AFB, acid-fast bacilli; IUT, International Union Against Tuberculosis formulation of solid egg medium; PYR, IUT medium with pyruvate supplementation; MB, MBBact, Biomerieux, Basingstoke, United Kingdom; MGIT, Mycobacteria Growth Indicator Tube, Becton Dickinson; R,I,E,P, rifampin, isoniazid, ethambutol, pyrazinamide; SIT, Spoligo-International-Type.
†SIT numbers: designations in International spoligotyping database (Spol DB4) (14).

Main Article

References
  1. Wells  AQ. Tuberculosis in wild voles. Lancet. 1937;i:1221. DOIGoogle Scholar
  2. Cavanagh  R, Begon  M, Bennett  M, Ergon  T, Graham  IM, De Haas  PE, Mycobacterium microti infection (vole tuberculosis) in wild rodent populations. J Clin Microbiol. 2002;40:3281–5. DOIPubMedGoogle Scholar
  3. Jahans  K, Palmer  S, Inwald  J, Brown  J, Abayakoon  S. Isolation of Mycobacterium microti from a male Charolais-Hereford cross. Vet Rec. 2004;155:373–4.PubMedGoogle Scholar
  4. Gunn-Moore  DA, Jenkins  PA, Lucke  VM. Feline tuberculosis: a literature review and discussion of 19 cases caused by an unusual mycobacterial variant. Vet Rec. 1996;138:53–8.PubMedGoogle Scholar
  5. Kremer  K, Van Soolingen  D, Van Embden  J, Hughes  S, Inwald  J, Hewinson  G. Mycobacterium microti: more widespread than previously thought. J Clin Microbiol. 1998;36:2793–4.PubMedGoogle Scholar
  6. Oevermann  A, Pfyffer  GE, Zanolari  P, Meylan  M, Robert  N. Generalized tuberculosis in llamas (Lama glama) due to Mycobacterium microti. J Clin Microbiol. 2004;42:1818–21. DOIPubMedGoogle Scholar
  7. Van Soolingen  D, Van der Zanden  AG, De Haas  PE, Noordhoek  GT, Kiers  A, Foudraine  NA, Diagnosis of Mycobacterium microti infections among humans by using novel genetic markers. J Clin Microbiol. 1998;36:1840–5.PubMedGoogle Scholar
  8. Horstkotte  MA, Sobottka  I, Schewe  CK, Schäfer  P, Laufs  R, Rüsch-Gerdes  S, Mycobacterium microti llama-type infection presenting as pulmonary tuberculosis in a human immunodeficiency virus-positive patient. J Clin Microbiol. 2001;39:406–7. DOIPubMedGoogle Scholar
  9. Niemann  S, Richter  E, Dalügge-Tamm  H, Schlesinger  H, Graupner  D, Königstein  B, Two cases of Mycobacterium microti–derived tuberculosis in HIV-negative immunocompetent patients. Emerg Infect Dis. 2000;6:539–42. DOIPubMedGoogle Scholar
  10. Foudraine  NA, Van Soolingen  D, Noordhoek  GT, Reiss  P. Pulmonary tuberculosis due to Mycobacterium microti in a human immunodeficiency virus–infected patient. Clin Infect Dis. 1998;27:1543–4. DOIPubMedGoogle Scholar
  11. Geiss  HK, Feldhues  R, Neimann  O, Nolte  R, Reiker  R. Landousy septicaemia (sepsis tuberculosa acutissima) due to Mycobacterium microti in an immunocompetent man. Infection. 2005;33:393–6. DOIPubMedGoogle Scholar
  12. Hart  PDA, Sutherland  I. BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life. BMJ. 1977;2:293–5. DOIPubMedGoogle Scholar
  13. Garcia-Pelayo  MC, Caimi  KC, Inwald  JK, Hinds  J, Bigi  F, Romano  MI, Microarray analysis of Mycobacterium microti reveals deletion of genes encoding PE-PPE proteins and ESAT-6 family antigens. Tuberculosis (Edinb). 2004;84:159–66. DOIPubMedGoogle Scholar
  14. Brudey  K, Driscoll  JR, Rigouts  L, Prodinger  WM, Gori  A, Al-Hajoj  SA, Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology. BMC Microbiol. 2006;6:23. DOIPubMedGoogle Scholar
  15. Fieschi  C, Dupuis  S, Catherinot  E, Feinberg  J, Bustamante  J, Breiman  A, Low penetrance, broad resistance, and favourable outcome of interleukin 12 receptor beta 1 deficiency: medical and immunological implications. J Exp Med. 2003;197:527–35. DOIPubMedGoogle Scholar

Main Article

Page created: July 06, 2010
Page updated: July 06, 2010
Page reviewed: July 06, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external